Scalable solvent-free production of liposomes.

The Journal of Pharmacy and Pharmacology
Swapnil KhadkeYvonne Perrie

Abstract

A major challenge faced with the manufacture of liposomes is the high volumes of organic solvents used during manufacturing. Therefore, we have implemented an organic solvent-free production method for drug-loaded liposomes and demonstrated its applicability with both aqueous core-loaded and bilayer-loaded drugs. Liposomes were produced by high shear mixing dry powder lipids with an aqueous buffer, followed by down-sizing using a Microfluidizer processor. Liposomes were purified via tangential flow filtration and characterised in terms of size, polydispersity index, zeta potential and drug loading. Doxorubicin-loaded PEGylated liposomes can be manufactured using this solvent-free method with particle sizes of 100-110 nm, low polydispersity index (PDI) (<0.2) and high drug loading (97-98%). If required, liposomes can be further down-sized via microfluidic processing without impacting drug loading. Similar results were achieved with non-PEGylated liposomes. With bilayer-loaded amphotericin B liposomes, again liposomes can be prepared within a clinically appropriate size range (100-110 nm in size, low PDI) with high drug loading (98-100%). We apply a simple and scalable solvent-free method for the production of both aqueous core o...Continue Reading

References

Sep 7, 1976·Biochimica Et Biophysica Acta·D Deamer, A D Bangham
Dec 2, 1976·Biochimica Et Biophysica Acta·J BrunnerH Hauser
Jul 8, 1992·Biochimica Et Biophysica Acta·D NeedhamD D Lasic
Apr 16, 1973·Biochimica Et Biophysica Acta·S Batzri, E D Korn
Aug 1, 1965·Journal of Molecular Biology·A D BanghamJ C Watkins
Mar 3, 1995·Science·D D Lasic, D Papahadjopoulos
Nov 5, 2002·Biophysical Journal·Montse Rovira-BruIgal Szleifer
Apr 8, 2003·Current Protein & Peptide Science·V P Torchilin, T S Levchenko
Dec 25, 2003·Antimicrobial Agents and Chemotherapy·Karen BartlettKishor M Wasan
Jan 20, 2004·The Journal of Antimicrobial Chemotherapy·Koji TakemotoYoshihito Niki
Jun 1, 2005·Chemistry and Physics of Lipids·Olga GarbuzenkoAba Priev
Apr 25, 2007·Langmuir : the ACS Journal of Surfaces and Colloids·Andreas JahnMichael Gaitan
May 3, 2007·Mycoses·Stefan SchwartzEckhard Thiel
Sep 26, 2007·Journal of Pharmaceutical Sciences·J J TorradoS Torrado-Santiago
Oct 31, 2007·Antimicrobial Agents and Chemotherapy·Jon A OlsonRichard T Proffitt
Jul 4, 2008·AAPS PharmSciTech·Louise A MeureFariba Dehghani
Nov 11, 2009·Journal of Liposome Research·Chiraz Jaafar-MaalejHatem Fessi
Jun 28, 2011·Journal of Liposome Research·Philippe GentineBenoît Frisch
Mar 7, 2014·International Journal of Nanomedicine·Anita HafnerIvan Pepić
Jul 28, 2015·Journal of Pharmaceutical Sciences·Islane Espirito SantoGiovanna Della Porta
Apr 25, 2017·Nature Nanotechnology·Sheetal R D'MelloKatherine M Tyner
Apr 21, 2018·International Journal for Parasitology. Drugs and Drug Resistance·Gert-Jan WijnantSimon L Croft
May 10, 2019·International Journal of Pharmaceutics·Benjamin RivnayAlex Nivorozhkin
Dec 18, 2019·Journal of Controlled Release : Official Journal of the Controlled Release Society·Daan J A CrommelinGert Storm
Feb 12, 2020·Nanomaterials·Mohammad HoushmandClaudia Giachino

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.